Back to RLMD

UBS Group AG → RLMD

UBS Group AG RLMD Position History

Relmada Therapeutics, Inc. • Healthcare

Quarters held
17
Latest value
$29K
Q3 2026
Peak value
$1.5M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$704
Q3 2025$119K
Q3 2025$34
Q4 2025$2K
Q4 2025$194K
Q4 2025$82
Q4 2025$4K
Q1 2026$2K
Q1 2026$825K
Q1 2026$54K
Q2 2026$2K
Q2 2026$749K
Q2 2026$27K
Q2 2026$316K
Q3 2026$1K
Q3 2026$1.5M
Q3 2026$29K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$29K7.6K——
Q3 2026$1.5M397.6K——
Q3 2026$1K350——
Q2 2026$316K45.7K——
Q2 2026$27K3.9K——
Q2 2026$749K108.2K——
Q2 2026$2K350——
Q1 2026$54K7.8K——
Q1 2026$825K118.5K——
Q1 2026$2K350——
Q4 2025$4K927——
Q4 2025$8217——
Q4 2025$194K40.2K——
Q4 2025$2K350——
Q3 2025$3417——
Q3 2025$119K59.4K——
Q3 2025$704350——

Other funds holding RLMD

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B